CNTA
Centessa Pharmaceuticals
CNTA
CNTA
58 hedge funds and large institutions have $577M invested in Centessa Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 49 → 58 (+9)
0.26% less ownership
Funds ownership: 74.52% → 74.25% (-0.26%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
58
Holding in Top 10
2
Calls
$169K
Puts
$32K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$11.7M | |
| 3 | +$8.06M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$2.36M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.3M |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$4.9M | |
| 3 | -$2.61M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$2.29M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.27M |